ATE454902T1 - Verwendung von shigella invaplex für den transport von funktionalen proteinen und transkriptionsaktiven nukleinsäuren durch säugetier-zellmembranen in vitro und in vivo - Google Patents

Verwendung von shigella invaplex für den transport von funktionalen proteinen und transkriptionsaktiven nukleinsäuren durch säugetier-zellmembranen in vitro und in vivo

Info

Publication number
ATE454902T1
ATE454902T1 AT04811761T AT04811761T ATE454902T1 AT E454902 T1 ATE454902 T1 AT E454902T1 AT 04811761 T AT04811761 T AT 04811761T AT 04811761 T AT04811761 T AT 04811761T AT E454902 T1 ATE454902 T1 AT E454902T1
Authority
AT
Austria
Prior art keywords
transport
vivo
nucleic acids
invaplex
cell membranes
Prior art date
Application number
AT04811761T
Other languages
English (en)
Inventor
Robert Kaminski
Edwin Oaks
Original Assignee
Us Gov Sec Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Sec Army filed Critical Us Gov Sec Army
Application granted granted Critical
Publication of ATE454902T1 publication Critical patent/ATE454902T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04811761T 2003-11-25 2004-11-23 Verwendung von shigella invaplex für den transport von funktionalen proteinen und transkriptionsaktiven nukleinsäuren durch säugetier-zellmembranen in vitro und in vivo ATE454902T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52463903P 2003-11-25 2003-11-25
PCT/US2004/039100 WO2005051421A2 (en) 2003-11-25 2004-11-23 Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo

Publications (1)

Publication Number Publication Date
ATE454902T1 true ATE454902T1 (de) 2010-01-15

Family

ID=34632916

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04811761T ATE454902T1 (de) 2003-11-25 2004-11-23 Verwendung von shigella invaplex für den transport von funktionalen proteinen und transkriptionsaktiven nukleinsäuren durch säugetier-zellmembranen in vitro und in vivo

Country Status (7)

Country Link
US (2) US7632659B2 (de)
EP (1) EP1701737B1 (de)
AT (1) ATE454902T1 (de)
AU (1) AU2004293031B2 (de)
CA (1) CA2548202C (de)
DE (1) DE602004025144D1 (de)
WO (1) WO2005051421A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE454902T1 (de) * 2003-11-25 2010-01-15 Us Gov Sec Army Verwendung von shigella invaplex für den transport von funktionalen proteinen und transkriptionsaktiven nukleinsäuren durch säugetier-zellmembranen in vitro und in vivo
CN101711165B (zh) * 2007-03-27 2016-02-24 以沃尔特里德军事研究所的名义,由美国陆军部部长为代表的美国政府 人造侵袭素复合物
US8722348B2 (en) 2008-05-28 2014-05-13 Wayne State University Method and composition for a protein transduction technology and its applications
KR102113829B1 (ko) 2013-10-25 2020-05-25 웨인 스테이트 유니버시티 단백질-유도 생체내 세포 재프로그래밍을 통한 세포 전환 방법, 시스템 및 조성물
KR102047502B1 (ko) * 2016-06-20 2019-11-22 셀라이온바이오메드 주식회사 포타슘 채널 단백질을 이용한 암 진단용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018355A2 (en) * 1998-09-30 2000-04-06 Walter Reed Army Institute Of Research Use of purified invaplex from gram negative bacteria as a vaccine
DE69923996D1 (de) 1998-10-21 2005-04-07 Univ Kansas Ct For Res Inc Methode für die herstellung von gereinigtem invasinprotein und seine anwendung
DE60218662T2 (de) 2001-05-18 2007-11-08 Walter Reed Army Institute Of Research Heterologer schutz, induziert durch immunisierung mit der invaplex-vakzine
ATE454902T1 (de) * 2003-11-25 2010-01-15 Us Gov Sec Army Verwendung von shigella invaplex für den transport von funktionalen proteinen und transkriptionsaktiven nukleinsäuren durch säugetier-zellmembranen in vitro und in vivo

Also Published As

Publication number Publication date
WO2005051421A3 (en) 2005-09-15
CA2548202A1 (en) 2005-06-09
EP1701737B1 (de) 2010-01-13
US7632659B2 (en) 2009-12-15
EP1701737A2 (de) 2006-09-20
US20100119543A1 (en) 2010-05-13
AU2004293031A1 (en) 2005-06-09
US8110354B2 (en) 2012-02-07
AU2004293031B2 (en) 2011-03-31
WO2005051421A2 (en) 2005-06-09
US20050215474A1 (en) 2005-09-29
CA2548202C (en) 2013-05-14
DE602004025144D1 (de) 2010-03-04

Similar Documents

Publication Publication Date Title
Sivagnanam et al. Exploring living multicellular organisms, organs, and tissues using microfluidic systems
Kang et al. Human liver sinusoid on a chip for hepatitis B virus replication study
Bachand et al. “Smart dust” biosensors powered by biomolecular motors
WO2007084342A3 (en) Codon optimi zed il- 15 and il- 15r-alpha genes for expression in mammalian cells
DK1685243T3 (da) Immortaliserede fuglecellelinjer til virusproduktion
Prosser et al. Integrated multi-assay culture model for stem cell chondrogenic differentiation
WO2016158417A1 (ja) 肝代謝物の毛細胆管様構造への蓄積と排泄を促進する肝細胞培養装置、並びに該肝細胞培養装置を用いた胆汁中又は血液中排泄感受性の候補化合物及び該候補化合物の肝代謝物の評価方法
Almeida et al. Perfusion and ultrasonication produce a decellularized porcine whole-ovary scaffold with a preserved microarchitecture
CN107831317A (zh) 犬冠状病毒抗体快速定量检测卡及使用方法
Hynes et al. Micropatterning of 3D microenvironments for living biosensor applications
DE60041243D1 (de) Gebrauchsverfaheren eines neuen lysyloxidase-verwandten proteins
Raibaut et al. Selectively activatable latent thiol and selenolesters simplify the access to cyclic or branched peptide scaffolds
Krysko et al. In vitro veritas: from 2D cultures to organ-on-a-chip models to study immunogenic cell death in the tumor microenvironment
CN208224282U (zh) 犬冠状病毒抗体定量快速检测系统
DE602004025144D1 (de) Verwendung von shigella invaplex für den transportven nukleinsäuren durch säugetier-zellmembranen in vitro und in vivo
Niu et al. An Engineered Protein-Based Building Block (Albumin Methacryloyl) for Fabrication of a 3D In Vitro Cryogel Model
Utsugi et al. Strategies for post-translational control of protein expression and their applications
CN103411818B (zh) 一种固定生物大分子的改性载玻片及方法
Nakazato et al. Protein delivery to insect epithelial cells in vivo: Potential application to functional molecular analysis of proteins in butterfly wing development
Maschietto et al. A live mammalian cells electroporation array for on-chip immunofluorescence
Baliga et al. Electroporation-and Liposome-Mediated Co-Transfection of Single and Multiple Plasmids
Jafari et al. Rapid discovery of illuminating peptides for instant detection of opioids in blood and body fluids
Arnold et al. Separation of membrane protein complexes by native LDS-PAGE
JP6099075B2 (ja) 核内から細胞質へのターゲットmRNAの輸送を促進する方法、タンパク質の発現方法および製造方法、ならびに、それに用いるキット
Cheremkhina et al. Influence of aerosolization on endothelial cells for efficient cell deposition in biohybrid and regenerative applications

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties